Digital Everyday drug discovery: How tech expands the potential of c... Discover how technology is making clinical trials more flexible and patient-friendly through tools like eCOA, eConsent, and wearables.
Digital Empowering health through innovation: Smartwatches as diagno... The capabilities of smartwatches are still very much evolving, and in recent years thoughts have turned to the possibility of using them as medical devices.
Partner Content Partner Content Respiratory Monitoring & AI Technologies Returning for the 2nd annual year, the Biosensors for Medical Wearables Conference will be held in October 24 – 25 2022 in Boston, MA, USA.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.